Wednesday, October 26, 2016

Casodex




In the US, Casodex (bicalutamide systemic) is a member of the following drug classes: antiandrogens, hormones/antineoplastics and is used to treat Prostate Cancer.

US matches:

  • Casodex

UK matches:

  • Casodex 150 mg Film-coated Tablets.
  • Casodex 50 mg Film-coated Tablets
  • Casodex 150 mg Film-coated Tablets. (SPC)
  • Casodex 50 mg Film-coated Tablets (SPC)

Ingredient matches for Casodex



Bicalutamide

Bicalutamide is reported as an ingredient of Casodex in the following countries:


  • Argentina

  • Aruba

  • Austria

  • Bahamas

  • Bahrain

  • Barbados

  • Belgium

  • Bermuda

  • Bosnia & Herzegowina

  • Brazil

  • Bulgaria

  • Canada

  • Chile

  • China

  • Colombia

  • Costa Rica

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Dominican Republic

  • Ecuador

  • Egypt

  • El Salvador

  • Estonia

  • Finland

  • France

  • Georgia

  • Germany

  • Ghana

  • Greece

  • Guatemala

  • Guyana

  • Haiti

  • Honduras

  • Hong Kong

  • Hungary

  • Iceland

  • Indonesia

  • Iran

  • Iraq

  • Ireland

  • Israel

  • Italy

  • Jamaica

  • Japan

  • Jordan

  • Kenya

  • Kuwait

  • Latvia

  • Lebanon

  • Libya

  • Lithuania

  • Luxembourg

  • Malawi

  • Malaysia

  • Malta

  • Mexico

  • Mozambique

  • Netherlands

  • Netherlands Antilles

  • Nicaragua

  • Nigeria

  • Norway

  • Oman

  • Panama

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sri Lanka

  • Sudan

  • Sweden

  • Switzerland

  • Syria

  • Taiwan

  • Tanzania

  • Thailand

  • Trinidad & Tobago

  • Tunisia

  • Turkey

  • Uganda

  • United Arab Emirates

  • United Kingdom

  • United States

  • Yemen

  • Zambia

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment